Hikma Pharmaceutical | Passività Correnti



Current Liabilities Cambiamento Data
Almirall EUR 274.01M 14.41M 2024-06
AstraZeneca USD 27.87B 1.94B 2024-12
Autolus Therapeutics Ltd 52.47M 11.57M 2024-09
Bayer EUR 28.95B 3.9B 2024-12
Fresenius EUR 6.09B 2.19B 2024-12
Galapagos EUR 335.08M 16.15M 2024-12
Genmab DKK 5.31B 723M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
GRIFOLS EUR 2.16B 199.43M 2024-12
Hikma Pharmaceutical USD 1.38B 41M 2024-06
Lonza CHF 3.58B 970M 2024-12
Merck EUR 10.46B 532M 2024-09
Orion EUR 273.4M 130.4M 2024-12
Recordati EUR 906.69M 19.47M 2024-09
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 30.03B 5.82B 2024-06
UCB EUR 3.53B 731M 2024-12



Hikma Pharmaceutical Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.